Skip to main content
. 2021 Apr 23;16(12):2383–2387. doi: 10.4103/1673-5374.313015

Figure 1.

Figure 1

Overview of preclinical evidence for lithium-induced neuroprotective mechanisms in distinct neurological diseases.

Preclinical studies have shown the neuroprotective potential of lithium in neurological diseases such as Parkinson’s disease, traumatic brain injury, Alzheimer’s disease, and ischemic stroke by affecting individual downstream signaling cascades.